Truvada (emtricitabine/tenofovir) to lower their risk of getting HIV

See the CDC's interim guidance for pre-exposure prophylaxis of HIV infection

You may have patients asking for Truvada (emtricitabine/tenofovir) to lower their risk of getting HIV.

Prophylaxis after exposure isn't new...it's standard practice for babies born to HIV-positive moms and people exposed to infected fluids.

Now there's evidence that CHRONIC prophylaxis reduces the risk of HIV infection in high-risk men who have sex with men.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote